LOGIN
AAOS: Fondaparinux appears to be associated with elevated blood coagulation factors
March 2014
AAOS: Fondaparinux appears to be associated with elevated blood coagulation factors
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Thrombogenicity and Platelet Function in Lower Extremity Total Joint Arthroplasty: A Prospective Randomized Study
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
51 patients undergoing elective total knee and hip arthroplasty were randomized to receive thromboprophylaxis with either subcutaneous injection of fondaparinux (2.5 mg) or aspirin (325 mg) plus compression stockings. The purpose of this study was to determine whether changes in thrombogenicity can be measured with blood coagulation factors and platelet counts. Analysis of blood drawn on postopera...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.